This company is a pharmaceutical manufacturer specializing in the development and production of anti-HIV medications, with a focus on innovative therapies. They possess self-developed technology for protein production and extraction from urine.
Key therapy areas include HIV/AIDS treatment and gastrointestinal disorders. They offer both prescription medications (e.g., Ainuovirine) and over-the-counter drugs like Sennae Folium Granules and Bacillus Cereus Tablets. The company operates across multiple regions, including the EU and North America, with a significant manufacturing presence in its home region. They actively participate in international conferences and publish research findings in medical journals.